 |
Bacitracin |
|---|---|
| Trade Name | Altracin |
| Orphan Indication | Antibiotic-associated pseudomembranous enterocolitis caused by toxins A and B elaborated by Clostridium difficile |
| USA Market Approval | USA |
| USA Designation Date | 1984-03-13 00:00:00 |
| Sponsor | A. L. Laboratories, Inc.;One Executive Drive, P.O. Box 1399;Fort Lee, New Jersey, 07024 |
